RxDoctor Payments Data

Kirsten Upton, PA

Physician Assistant · Centerville, OHNPI 1083156459

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.8% of the total across 1,045 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,570in general payments, 2019–2025

Across 1,045 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • MDD US Operations, LLC$1K
  • UCB, Inc.$1K
  • Lilly USA, LLC$991
  • Novartis$838
  • Neurocrine Biosciences, Inc.$801
  • plus $11K from 54 others

What the payments were for

  • Speaking & faculty fees$2681%
  • Food & beverage$18,16398%
  • Education$1391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)143$2,645
MDD US Operations, LLC36$1,282
UCB, Inc.64$1,029
Lilly USA, LLC77$991
Novartis70$838
Neurocrine Biosciences, Inc.49$801
Pfizer50$761
Biogen41$741
SK Life Science, Inc.28$613
Amgen41$592
AstraZeneca(2 entities)30$584
Amneal Pharmaceuticals LLC40$577
Acadia Pharmaceuticals Inc36$507
Lundbeck LLC22$459
Eisai Inc.22$446
Genentech USA, Inc.22$379
Acorda Therapeutics, Inc21$331
EMD Serono, Inc.15$331
Biohaven Pharmaceutical Holding Company Ltd.20$318
Teva Pharmaceuticals USA, Inc.17$314
Biohaven Pharmaceuticals, Inc.21$296
Takeda Pharmaceuticals U.S.A., Inc.10$260
Argenx US, Inc.11$252
Sumitomo Pharma America, Inc.11$224
Insightec,inc3$209
Sunovion Pharmaceuticals Inc.12$203
Jazz Pharmaceuticals Inc.10$197
Supernus Pharmaceuticals, Inc.11$158
Abbott3$158
Merz Pharmaceuticals, LLC7$150
Sanofi7$145
Ipsen Biopharmaceuticals, Inc9$137
Greenwich Biosciences, Inc.8$136
TG Therapeutics, Inc.6$122
Octapharma USA, Inc.7$114
Neurelis, Inc.6$106
Avanir Pharmaceuticals, Inc.6$104
Harmony Biosciences LLC4$96
GE HealthCare3$95
Alnylam Pharmaceuticals Inc.4$85
Otsuka America Pharmaceutical, Inc.3$73
CSL Behring5$70
Adamas Pharmaceuticals, Inc.5$68
Amylyx Pharmaceuticals, Inc.3$56
Sandoz2$51
Collegium Pharmaceutical, Inc.2$44
Johnson & Johnson2$44
Axsome Therapeutics, Inc.2$43
Grifols USA, LLC2$36
Cala Health, Inc.2$34
Currax Pharmaceuticals LLC2$32
Medtronic2$32
Monteris Medical Corporation1$28
Boston Scientific1$26
Averitas Pharma Inc.1$25
Kyowa Kirin, Inc.1$23
Philips North America LLC1$22
Scilex Pharmaceuticals Inc.1$21
Banner Life Sciences, LLC1$20
Corium, LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,570 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$63,490
Medicare patients
434
Services billed
733

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant99$109,820
QuliptaAtogepant81$96,903
NuplazidPimavanserin Tartrate14$65,924
GocovriAmantadine Hcl18$60,685
Aimovig AutoinjectorErenumab-Aooe45$42,593
Emgality PenGalcanezumab-Gnlm60$40,775
Nurtec OdtRimegepant Sulfate35$38,601
Tetrabenazine21$23,194
NamzaricMemantine Hcl/Donepezil Hcl25$18,890
Ajovy AutoinjectorFremanezumab-Vfrm14$15,784
Memantine Hcl306$12,252
Ajovy SyringeFremanezumab-Vfrm12$9,109
Rivastigmine34$8,819
Entacapone21$7,000
Carbidopa-LevodopaCarbidopa/Levodopa341$6,507

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta, Namzaric$2,645$225,613205 claims
Acadia Pharmaceuticals IncNuplazid$507$65,92414 claims
MDD US Operations, LLCGocovri$1,282$60,68518 claims
PfizerNurtec Odt$761$38,60135 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Centerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →